GlobeStar Therapeutics Corporation (GSTC)
Develops experimental drugs to treat multiple sclerosis and brain diseases
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
GSTC trades at $0.0001, well above both its 50- and 200-day moving averages, suggesting strength in its intermediate trend. Analyst coverage appears thin or unavailable for this micro-cap stock. The current valuation reflects the extremely early or speculative stage typical of penny stocks.
What’s behind the score
Price trendAbove its 50- & 200-day averages
Market cap
$124,110
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—